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Background: Treatment of cellulite using a 1440-nm YAG wavelength laser with side-firing fiber has proven safe and effective, lasting at least 6 months.
Objectives: The authors evaluate the safety and efficacy of a single, subdermal procedure to treat the underlying structure of cellulite for at least 1 year.
Methods: Fifty-seven patients underwent a 3-step cellulite treatment with a 1440-nm Nd:YAG laser with a side-firing fiber and temperature-sensing
cannula. Efficacy was measured by the blinded evaluators to distinguish baseline photos from those taken at 12 months posttreatment, with results on a
5-point, 2-category ordinal photonumeric scale when comparing baseline photos to 12 months posttreatment. Subject and physician satisfaction was as-
sessed based on completion of a satisfaction survey. Adverse events (AE) were recorded throughout the study. Twelve month data were analyzed and com-
pared to 6 month data.
Results: Evaluators chose baseline photographs 97% on average from 6 (−1, +2) months and 91% from the 12 (−3, +2) months posttreatment pho-
tographs. At 6 (−1, +2) months, the average improvement score was 1.7 for dimples and 1.1 for contour irregularities. At 12 (−3, +2) months, the
average improvement score was 1.4 for dimples and 1.0 for contour irregularities. The average satisfaction score for the physician was 5.6 and the patient
was 5.3 on a 6-point scale.
Conclusions: A single, 3-step, minimally invasive laser treatment using a 1440-nm Nd:YAG laser, side-firing fiber, and temperature-sensing cannula to
treat the underlying structure of cellulite proved to be safe and maintained effectiveness at least 1 year post treatment.
Level of Evidence: 2
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The underlying structure of cellulite has been studied and
explained by histology and magnetic resonance imaging
(MRI).1 In normal skin, the hypodermal fat layer is divided
into chambers by septae. The fibrous tissue strands extend
from the dermal layer, through the hypodermal fat layer,
and connect to the underlying muscle layer. However, in
women with cellulite, the septae sclerose contract, holding
the skin at an inflexible length, while hypodermal fat lobules
extend upward into the dermis. These structural changes
cause a heterogeneous effect on the skin surface which
affects at least 85% of post-pubertal women.2 With age, the
integrity of the dermis is further compromised as skin thick-
ness and elasticity decreases.3 Treating any or all of the
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anatomical features of cellulite restores the skin to a more
homogenous state, reducing the appearance of cellulite.
Many treatment methods are available to treat cellulite
such as massage,4 low-level light energy therapy from laser
light,5 intense pulse light, radiofrequency,6 diode laser, in-
frared light, and ultrasound with and without mechanical
massage as well as injectables and topicals7-15 and subcision,
both mechanical and thermal.16-17 The results of these studies
have reported mild and temporary improvement.
In 2008, the first use of a laser procedure to treat cellulite
subdermally was reported.1 In that study, the authors re-
ported 84.6% of patients rated the results from treatment as
either good or excellent. In 2011, a report was published of
10 patients treated with a 1440-nm Nd:YAG laser and a
newly developed fiber with a precise delivery capability
(SideLight 3D; Cynosure, Westford, MA) enclosed in a
thermal-sensing cannula (ThermaGuide; Cynosure).2 This
new fiber technology provided a highly targeted means of
delivering laser energy into the targeted anatomical struc-
tures underlying the cellulite. The thermal-sensing cannula
is integrated with the laser delivery system to provide a safe
and even distribution of energy to the treatment site. At
one year, study findings showed mean skin thickness and
skin elasticity increased significantly. Subjective physician
and subject evaluation indicated improvement, high
subject satisfaction, and minimal adverse events.
METHODS
An IRB (Independent Investigation Review Board INC,
Plantation, FL, ), FDA-approved multicenter studied was
conducted beginning in November 2010 and 6 month data
were published.18 The same group of patients were provid-
ed an optional 1 year follow-up to assess longer term
results which are reported in this study and evaluated from
the period of November 2011 through April 2012.
Pretreatment
A total of 57 female patients at five study centers for this
IRB-approved clinical trial were enrolled and treated.
Prospective patients were excluded from participation in
the trial if any of the following were present: surgical/non-
surgical treatment for cellulite in past 6 months; history of
thrombophlebitis, acute infections, heart failure or keloid
formation; recent antiplatelet, anticoagulant, thrombolytic,
vitamin E or anti-inflammatory therapy; intolerance to an-
esthesia or medications which produce a photosensitizing
effect; pregnant, breast feeding or planning a pregnancy, or
unable to maintain a diet and exercise routine during the
study period.
Patients who met the inclusion/exclusion criteria were
consented. Basic chemistry panel was taken typical to stan-
dard practice for surgery, and patients were given antibiotics
to be taken the evening prior to treatment and continued
7 days posttreatment. Weight was recorded and photographs
were taken pretreatment and at all follow-up visits.
Treatment
With the patient in a standing position, a treatment grid of 5
cm×5 cm squares (sector) was marked over the treatment
area. Lumps at least 3 cm×3 cm square were marked in
green, and dimples at least 1 cm long were marked in red
(Figure 1).
With the patient positioned either in the lateral decubitus
or prone position, the skin was prepared with povidone-
iodine antiseptic. A small amount of lidocaine was injected
at chosen injection sites. Using a small blade, 1 mm incisions
were made. Distal incision points at the lower border of the
marked grid were preferred for proper drainage posttreat-
ment. Proximal incisions at the upper border of the marked
grid were made as necessary. Each defined sector was
infused with up to 60 mL of tumescent anesthesia mixture
(50 mL of 0.5% lidocaine, 1 mg epinephrine per liter of
warm saline, and 20 mL of 8.4% sodium bicarbonate).
Patients underwent a single procedure with the 1440-nm
laser in the bilateral thighs and/or buttocks. The cannula
with side-firing fiber tip was passed through the incisions,
Figure 1. The total treatment dosage in joules is based upon
the size of the area, the evaluation of the skin, and the grade
of cellulite. The average amount of joules used in this study
was 1000 J per 5×5 cm2. Generally in step 1, 300 joules are
allocated for mounds 3 cm and 600 joules for mounds 5 cm. In
step 2, 100 joules are allocated for dimples 1 cm, 300 joules for
dimples 3 cm and 5cm dimples received 600 joules. In step 3,
the remaining joules are applied to the skin subdermally, up to
approximately 1000 joules. Deposition of up to an additional
300 to 500 joules/square was allowed in addition to 1000
joules at the investigator’s discretion for more complex presen-
tations, such as thicker fibrous bands and larger fat mounds.
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delivering energy at 8 to 10Watts and 25 Hz. The temperature-
sensing cannula was set to monitor subdermal tempera-
tures, and would sound at a minimum of 47°C and a
maximum of 52°C.
Four to six squares were treated at one time. A 3-step
procedure was used.2,18 In step 1, the laser cannula-fiber is
placed in the down position 1 to 2 cm below the dermis
within the selected 5× 5 cm squares and passed in a fan-
shaped manner to treat the excess hypodermal fat; step 2,
the cannula-fiber is moved sideways in a fanning pattern
perpendicular to the marked depressions 3 to 5 mm below
the dermis to subsize taut septal bands and release dimples;
step 3, the fiber is placed in the superficial position 1 to 3 mm
below the dermis to heat the entire skin in the 5 cm×5 cm
square to increase skin collagen and elastin for tissue tighten-
ing and dermal thickening (Figures 2-4).2
Following laser treatment, aspirate generated by the cel-
lulite treatment is removed through soft tissue massage and
milking, to allow an effluent of the tumescent fluid and
some small amounts of the liquefied fat, serum, and blood
to be drained through the access incisions. A rolled-up
towel or medical roller was sometimes used to facilitate the
process. Standard pressure dressings were applied to the
treated areas, and patients were instructed to wear a com-
pression garment for the next 2 to 3 weeks. Standard prac-
tice postoperative instructions were given. Patients were
informed of common side effects such as bruising, swell-
ing, pain, numbness, and itching that may occur.
A camera system (Canfield Scientific, Fairfield, NJ) was
set-up in each of five clinical centers. Dedicated photogra-
phy rooms were used and a mat was used to repeat posi-
tioning. A lumen meter was used to record the exact
amount of light falling on the patient. The photographs of
thighs and buttocks were taken in a standardized manner;
in the same room, with the same camera fixed at the same
location by the same person hired for reproducibility.
RESULTS
Demographics
Of 57 subjects treated at baseline, 47 (82%) were present for
the 6 (−1, +2) months evaluation representing 5 study
centers and 30 (53%) patients returned for the 12 (−3, +2)
months visit representing 4 study centers (Table 1). The origi-
nal 57 patients had an average age of 43.3 years (range, 21-55
years), and body mass index (BMI) of 25.1 (range, 20-33).
The 47 patients with a six month follow-up had an average
age of 42.8 years (range, 21-55 years) and BMI of 25.0 (range,
20-33). The 30 patients with a one year follow-up had an
average age of 41.8 years (range, 21-55 years) and BMI of 25.1
(range, 21-31). The majority of patients were of Caucasian
and Hispanic descent with Fitzpatrick Skin Types of mostly
type II and III (Table 2).
Figure 2. Illustration of bidirectional fiber performing disrup-
tion of the deeper fat to lessen the height of the raised mounds.
Reprinted with permission from Cynosure (Westford,
Massachusetts).
Figure 4. Illustration of bidirectional fiber performing delivery
of superficial energy to the dermis. Reprinted with permission
from Cynosure (Westford, Massachusetts).
Figure 3. Illustration of bidirectional fiber performing laterally
directed thermal subcision for the disruption of depressed ver-
tical septae. Reprinted with permission from Cynosure
(Westford, Massachusetts).
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Identifying Treatment Time points
Evaluators were asked to identify the pretreatment (baseline)
photographs from the 6 (−1, +2) month and 12 (−3, +2)
month posttreatment photographs.
Six Month (−1, +2) Evaluation
Each of the 47 subjects had 2 treatment sites (thighs or but-
tocks) to be assessed, totaling 94 photographs. However,
only 62 sites were evaluable because 32 photographs were
of inadequate quality. Therefore 62 pairs of treatment area
photographs were analyzed in paired analysis (62 baseline,
62 six months posttreatment photographs). For the 62 paired
photographs, 97% (average) of the baseline photographs
were correctly chosen by the evaluators (Table 3).
Twelve Month (−3, +2) Evaluation
Each of the 30 subjects had 2 treatment sites to be assessed
totaling 60 photographs. However, only 52 sites were
evaluable because 8 photographs were of inadequate
quality. Therefore 52 treatment area photographs were ana-
lyzed in paired analysis (52 baseline, 52 twelve months
posttreatment photographs). For the 52 paired photographs,
91% (average) of the baseline photographs were correctly
chosen by the evaluators (Table 3).
Level of Improvement
A validated scale was designed that presented two main
clinical morphologic features of cellulite (categories): (A)
number of evident dimples (Figure 5); and (B) severity of
linear undulations (contour irregularities) (Figure 6). The
severity of each category was graded on a 5-point scale
(0-4).18 Responder rates were then calculated. A responder
is defined as a treatment site having a baseline score greater
than zero with an improvement score equal to or greater
than one. Inter-rater reliability was determined by compar-
ing paired evaluator scores and expressed as a weighted
Kappa value. Kappa values above 0.50 were recognized as
demonstrating reasonable agreement.
Six Month (−1, +2) Evaluation
One of the 62 treatment sites evaluated at 6 months did
not have dimples at baseline. Fifty-eight of 61 (95%) of
dimpled treatment sites and 61 of 62 (98%) contour irregu-
larity sites had at least a ≥1 score improvement (Table 4).
The average improvement score was 1.7 for dimples and
1.0 for contour irregularities (Table 4).
Table 1. Number of Patients per Clinical Center
Months Center
1 2 3 4 5 Total
0 (Baseline) 10 7 12 13 15 57
6 (−1,+2) Months 5 5 11 12 14 47
12(−1,+2) Months 0 3 8 8 11 30
Table 2. Patient Demographics
Baseline (N = 57) 6 (−1, +2)
Months (N = 47)
12 (−3, +2)
Months (N = 30)
Age [SD
(Min-Max)]
43.3 [8.7 (21-55)] 42.8 [8.9 (21-55)] 41.8 [9.3 (21-55)]
BMI [SD
(Min-Max)]
25.1 [3.0 (20-33)] 25.0 [3.1 (20-33)] 25.1 [2.9 (21-31)]
Fitzpatrick Score
I 8 8 4
II 21 17 12
III 23 18 11
IV 3 3 2





Caucasian 43 35 22
Hispanic 12 10 6
Table 3. Percentage of Correct Selection of Baseline Photographs
Evaluator 6 (−1, +2)
Months (n = 62)
12 (−3, +2)
Months (n = 52)
P Valuea
1 60 (97) 48 (92) <.001
2 59 (95) 47 (91) <.001




For the 47 subjects at 6 months there were 94 treatment sites, of which 62 (66%) were
suitable for photographic evaluation. For the 30 subjects at 12 months there were 60 treatment
sites, of which 52 (87%) were suitable for photographic evaluation. aThe P value is based on a
chi-square test. P values < .001 shows statistical significance that the selection of baseline
photographs is not based on random selection.
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Twelve Month (−3, +2) Evaluation
One photograph of the 52 treatment sites at 12 months (−3,
+2) did not have dimples and one site did not have contour
irregularities at baseline. Forty-six of 51 (90%) treatment
sites with dimples and contour irregularities had at least a
≥1 score improvement. The average improvement score was
1.4 for dimples and 1.0 for contour irregularities (Table 4).
Satisfaction
Physician and subject satisfaction was assessed by a ques-
tionnaire based on a 6-point Likert Scale: 6= extremely sat-
isfied, 5= satisfied, 4= slightly satisfied, 3= slightly
dissatisfied, 2=dissatisfied, and 1=extremely dissatisfied.
Patients were provided a satisfaction survey with the
patient ID on the survey and asked to respond to the
questionnaire at the physician’s office immediately prior to
meeting with the physician. The physician segment was
completed by the physician after the follow-up visit.
At the 6 month visit, 45 subjects had completed ques-
tionnaires and the average score for the physician was 5.4
and the subject was 5.0.
At the 12 month visit, 11 subjects had completed ques-
tionnaires and the average score for the physician was 5.6
and the subject was 5.3 (Table 5).
Safety
The laser treatment continues to demonstrate an excellent
safety profile. No adverse events reported at 12 months.
Two representative cases are presented in Figures 7 and 8.
Figure 5. Scale for evaluating cellulite dimples, in which a dimple is an isolated circular or oval-shaped depression on the surface
of the skin. Each photo represents a number of dimples. Five circles are placed in each photo for evaluation purposes. The circle
may or may not contain a dimple. This is done so the evaluator is not confused by nondimpling irregularities, but not biased by
being told exactly where the dimples are located. (A) Score 0 (no dimples); (B) score 1 (1 dimple); (C) score 2 (2 dimples); (D)
score 3 (3 dimples); (E) score 4 (4 or more dimples). From DiBernardo et al18 reprinted with permission from Oxford University
Press.
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DISCUSSION
This multicenter study showed sustained improvement in
the appearance of cellulite and continued safety following a
single, 3-step cellulite treatment with the 1440-nm Nd:YAG
side-firing laser through 12 months.
Figure 6. Scale for evaluating contour irregularities. The irregularities become more severe as more concavity and convexity occur
in the linear undulations. (A) Score 0 (none—no depressions or raised areas); (B) score 1 (superficial: generalized, small depres-
sions with no protuberances; (C) score 2 (mild: pattern of mild linear undulations with alternating areas of protuberances and de-
pressions); (D) score 3 (moderate: pattern of moderate linear undulations with alternating areas of protuberances and
depressions); (E) score 4 (severe: severe generalized linear undulations with alternating areas of protuberances and depressions).
From DiBernardo et al18 reprinted with permission from Oxford University Press.
Table 4. Responder Improvement Scores
Responder (Treatment Sites) With ≥1 Score Improvement per Category
6 (−1, +2) Months 12 (−3, +2) Months
Dimples Contour Dimples Contour
Baseline score > 0 61 62 51 51
Improvement score≥ 1 58 61 46 46
% Improvement 95 98 90 90



















5.4 5.0 5.6 5.3
Mode 6 5 6 6
aLikert 6-point scale: 6 = extremely satisfied, 5 = satisfied, 4 = slightly satisfied, 3 = slightly
dissatisfied, 2 = dissatisfied, 1 = extremely dissatisfied.
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Since the 12 month visit was optional, the 12 month
population consisted of 30 subjects (53%) compared to 47
subjects (82%) at 6 months (Table 1).
Data were analyzed separately per time point for each
sub population. To show sustained efficacy over a 1 year
period, the data were tested using a sub population of sub-
jects that presented at the two time points of 6 and
12 months.
A chi-square test was used to statistically confirm that
evaluators identifying pretreatment photographs exceeded
the chance of random selection. The evaluators chose the
baseline photographs 97% on average from 6 (−1/+2)
months, and 91% from 12 (−3/ +2) photographs. The P
value comparing 6 month and 12 month data was >0.05,
confirming that there was no significant difference in effica-
cy between the 6 (−1/+2) month and 12 (−3/+2) month
visits, and proving sustainability at 1 year (Table 3).
A paired t test was used to assess improvement scores
based on the validated scale. At 6 (−1, +2) months, the
average improvement score was 1.7 for dimples and 1.1
for contour irregularities. At 12 (−3, +2) months, the
average improvement score was 1.4 for dimples and 1.0
for contour irregularities. The P value was >0.05 when
comparing scores at 6 months vs 12 months, confirming
Figure 8. (A) This 39 year-old woman presented with moderate cellulite. (B) One year after a single treatment with the 1440-nm
Nd:YAG laser. The dotted line encloses the treatment area.
Figure 7. (A) This 39-year-old woman presented with moderate-severe cellulite. (B) One year after a single treatment with the
1440-nm Nd:YAG laser. The dotted line encloses the treatment area.
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no significant difference in improvement scores between
the 6 (−1/+2) month and 12 (−3/+2) month time points
(Table 6).
Data were consistent across clinical centers (Table 7).
When improvement scores were analyzed relative to weight
change, there was no correlation. Throughout the study,
patient and physician satisfaction was high. Incidence of
adverse events were recorded throughout the course of the
study. No events were reported between 6 months and
12 months.
Potential limitations in a multicenter study such as this can
be inconsistencies of measurements and photography from
center to center. These effects are magnified with a condition
such as cellulite due to the exact lighting that is required con-
sistently and reproducible measurements for the ultrasound.
To overcome these obstacles, third party photography was
performed in each center (Canfield Scientific, Fairfield, NJ)
and well as third party evaluation of the photographs. In
addition, the same ultrasonographer was used on all pa-
tients, at all centers, and at all time points
CONCLUSION
The Cellulaze laser system provides a sustainable improve-
ment in the appearance of cellulite for at least 1 year, as seen
in this study. Other publications have shown results main-
taining at least 3 years. Data to date have shown this single
laser procedure to have an outstanding safety profile with a
high satisfaction rate for both physicians and subjects.
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